{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T19:53:46Z","timestamp":1791057226251,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2025A1515012354"],"award-info":[{"award-number":["2025A1515012354"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270424"],"award-info":[{"award-number":["82270424"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82400470"],"award-info":[{"award-number":["82400470"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.bcp.2026.118467","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:04:40Z","timestamp":1789139080000},"page":"118467","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["Fenbufen suppresses VSMC phenotypic switching and neointimal hyperplasia by targeting HAS2"],"prefix":"10.1016","volume":"254","author":[{"given":"Yunxiang","family":"Long","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuyin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhong","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8424-8805","authenticated-orcid":false,"given":"Luoxing","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bcp.2026.118467_b0005","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jacc.2022.05.017","article-title":"Coronary In-Stent Restenosis: JACC State-of-the-Art Review","volume":"80","author":"Giustino","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118467_b0010","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s11886-025-02249-0","article-title":"In-Stent Restenosis: Incidence, Mechanisms, and Treatment Options","volume":"27","author":"Sola","year":"2025","journal-title":"Curr. Cardiol. Rep."},{"issue":"3","key":"10.1016\/j.bcp.2026.118467_b0015","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1152\/physrev.00041.2003","article-title":"Molecular regulation of vascular smooth muscle cell differentiation in development and disease","volume":"84","author":"Owens","year":"2004","journal-title":"Physiol. Rev."},{"issue":"17","key":"10.1016\/j.bcp.2026.118467_b0020","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1093\/eurheartj\/ehae911","article-title":"CCN5 suppresses injury-induced vascular restenosis by inhibiting smooth muscle cell proliferation and facilitating endothelial repair via thymosin beta4 and Cd9 pathway","volume":"46","author":"Zhang","year":"2025","journal-title":"Eur. Heart J."},{"issue":"12","key":"10.1016\/j.bcp.2026.118467_b0025","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1161\/CIRCULATIONAHA.123.063332","article-title":"Epigenetic Induction of Smooth Muscle Cell Phenotypic Alterations in Aortic Aneurysms and Dissections","volume":"148","author":"Chakraborty","year":"2023","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.bcp.2026.118467_b0030","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.031121","article-title":"Phenotypic Switching of Vascular Smooth Muscle Cells in Atherosclerosis","volume":"12","author":"Chen","year":"2023","journal-title":"J. Am. Heart Assoc."},{"issue":"2","key":"10.1016\/j.bcp.2026.118467_b0035","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/cvr\/cvs115","article-title":"Smooth muscle cell phenotypic switching in atherosclerosis","volume":"95","author":"Gomez","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bcp.2026.118467_b0040","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.876639","article-title":"Clinical use of Hydrogen Sulfide to Protect against Intimal Hyperplasia","volume":"9","author":"Macabrey","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"issue":"4","key":"10.1016\/j.bcp.2026.118467_b0045","doi-asserted-by":"crossref","first-page":"191","DOI":"10.12793\/tcp.2023.31.e18","article-title":"A review of the current state in neointimal hyperplasia development following endovascular intervention and minor emphasis on new horizons in immunotherapy","volume":"31","author":"Dinc","year":"2023","journal-title":"Transl Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.bcp.2026.118467_b0050","doi-asserted-by":"crossref","DOI":"10.1186\/s43556-026-00477-6","article-title":"Neointimal hyperplasia and vascular restenosis: from molecular mechanisms to therapeutic interventions","volume":"7","author":"Yi","year":"2026","journal-title":"Mol Biomed"},{"issue":"4","key":"10.1016\/j.bcp.2026.118467_b0055","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/BF00920340","article-title":"The pharmacology of fenbufen, 3-(4-biphenylylcarbonyl)propionic acid, and 4-biphenylacetic acid, interesting antiinflammatory-analgesic agents","volume":"1","author":"Sloboda","year":"1976","journal-title":"Inflammation"},{"issue":"1","key":"10.1016\/j.bcp.2026.118467_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-198121010-00001","article-title":"Fenbufen: a review of its pharmacological properties and therapeutic use in rheumatic diseases and acute pain","volume":"21","author":"Brogden","year":"1981","journal-title":"Drugs"},{"issue":"4A","key":"10.1016\/j.bcp.2026.118467_b0065","first-page":"716","article-title":"The pharmacological properties of fenbufen","volume":"30","author":"Sloboda","year":"1980","journal-title":"A Review, Arzneimittelforschung"},{"issue":"1","key":"10.1016\/j.bcp.2026.118467_b0070","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25010435","article-title":"Dissecting CYP1A2 Activation by Arylalkanoic Acid Prodrugs toward the Development of Anti-Inflammatory Agents","volume":"25","author":"Occhiuzzi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bcp.2026.118467_b0075","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1161\/CIRCRESAHA.113.301033","article-title":"Cyclooxygenase-2-derived prostaglandin E(2) promotes injury-induced vascular neointimal hyperplasia through the E-prostanoid 3 receptor","volume":"113","author":"Zhang","year":"2013","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.bcp.2026.118467_b0080","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1161\/ATVBAHA.123.320045","article-title":"Prostanoids in Cardiac and Vascular Remodeling","volume":"44","author":"Ricciotti","year":"2024","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"9","key":"10.1016\/j.bcp.2026.118467_b0085","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/s41569-020-0366-z","article-title":"Cardiovascular effects and safety of (non-aspirin) NSAIDs","volume":"17","author":"Schjerning","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"issue":"3","key":"10.1016\/j.bcp.2026.118467_b0090","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1172\/JCI124508","article-title":"Platelet-derived miR-223 promotes a phenotypic switch in arterial injury repair","volume":"129","author":"Zeng","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.bcp.2026.118467_b0095","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.2042-7158.1994.tb03259.x","article-title":"Fenbufen pretreatment potentiates the anticonvulsant activity of CPPene and NBQX in DBA\/2 mice","volume":"46","author":"De Sarro","year":"1994","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118467_b0100","article-title":"Fenbufen Alleviates Severe Acute Pancreatitis by Suppressing Caspase-1\/Caspase-11-mediated Pyroptosis in mice","volume":"17","author":"Shen","year":"2024","journal-title":"Curr. Mol. Pharmacol."},{"issue":"4A","key":"10.1016\/j.bcp.2026.118467_b0105","first-page":"707","article-title":"Disposition and metabolism of fenbufen in several laboratory animals","volume":"30","author":"Chiccarelli","year":"1980","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.bcp.2026.118467_b0110","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.matbio.2022.06.001","article-title":"3'UTR shortening of HAS2 promotes hyaluronan hyper-synthesis and bioenergetic dysfunction in pulmonary hypertension","volume":"111","author":"Tseng","year":"2022","journal-title":"Matrix Biol."},{"issue":"7","key":"10.1016\/j.bcp.2026.118467_b0115","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1111\/jocd.15027","article-title":"Designing topical hyaluronic acid technology-size does matter","volume":"21","author":"Widgerow","year":"2022","journal-title":"J. Cosmet. Dermatol."},{"issue":"3","key":"10.1016\/j.bcp.2026.118467_b0120","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s11373-007-9150-x","article-title":"A20 attenuates vascular smooth muscle cell proliferation and migration through blocking PI3k\/Akt singling in vitro and in vivo","volume":"14","author":"Wang","year":"2007","journal-title":"J. Biomed. Sci."},{"issue":"6","key":"10.1016\/j.bcp.2026.118467_b0125","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.7150\/ijbs.101391","article-title":"Integrin beta3-mediated platelet extracellular vesicle adhesion facilitates vascular smooth muscle cell dysfunction in postinjury intimal hyperplasia","volume":"21","author":"Zhuang","year":"2025","journal-title":"Int. J. Biol. Sci."},{"issue":"2","key":"10.1016\/j.bcp.2026.118467_b0130","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/CIRCRESAHA.112.272302","article-title":"MAPK phosphorylation of connexin 43 promotes binding of cyclin E and smooth muscle cell proliferation","volume":"111","author":"Johnstone","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2026.118467_b0135","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.biopha.2017.07.108","article-title":"Desalted Salicornia europaea extract attenuated vascular neointima formation by inhibiting the MAPK pathway-mediated migration and proliferation in vascular smooth muscle cells","volume":"94","author":"Won","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"14","key":"10.1016\/j.bcp.2026.118467_b0140","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1158\/0008-5472.CAN-16-2545","article-title":"Akt Signaling is Sustained by a CD44 Splice Isoform-Mediated positive Feedback Loop","volume":"77","author":"Liu","year":"2017","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.bcp.2026.118467_b0145","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1074\/jbc.M709051200","article-title":"Hyaluronan-CD44-ERK1\/2 regulate human aortic smooth muscle cell motility during aging","volume":"283","author":"Vigetti","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2026.118467_b0150","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s12012-011-9123-1","article-title":"Role of COX-2 in the bioactivation of methylenedianiline and in its proliferative effects in vascular smooth muscle cells","volume":"11","author":"Hebert","year":"2011","journal-title":"Cardiovasc. Toxicol."},{"issue":"11","key":"10.1016\/j.bcp.2026.118467_b0155","first-page":"1","article-title":"Prostaglandin D(2) stimulates phenotypic changes in vascular smooth muscle cells","volume":"51","author":"Lee","year":"2019","journal-title":"Exp. Mol. Med."},{"issue":"3","key":"10.1016\/j.bcp.2026.118467_b0160","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1161\/01.CIR.0000135467.43430.16","article-title":"Celecoxib, a cyclooxygenase-2 inhibitor, reduces neointimal hyperplasia through inhibition of Akt signaling","volume":"110","author":"Yang","year":"2004","journal-title":"Circulation"},{"issue":"6653","key":"10.1016\/j.bcp.2026.118467_b0165","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1136\/bmj.297.6653.921-e","article-title":"Haemolytic anaemia associated with fenbufen","volume":"297","author":"Martland","year":"1988","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.bcp.2026.118467_b0170","doi-asserted-by":"crossref","first-page":"744","DOI":"10.2169\/naika.77.744","article-title":"A case of convulsion, loss of consciousness and subsequent acute renal failure caused by enoxacin and fenbufen","volume":"77","author":"Morita","year":"1988","journal-title":"Nippon Naika Gakkai Zasshi"},{"issue":"6663","key":"10.1016\/j.bcp.2026.118467_b0175","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1136\/bmj.297.6663.1614-a","article-title":"Severe hypersensitivity reaction to fenbufen","volume":"297","author":"Muthiah","year":"1988","journal-title":"BMJ"},{"issue":"852","key":"10.1016\/j.bcp.2026.118467_b0180","first-page":"550","article-title":"Fenbufen: adverse reactions affecting the skin","volume":"101","author":"Edwards","year":"1988","journal-title":"N. Z. Med. J."},{"issue":"11","key":"10.1016\/j.bcp.2026.118467_b0185","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1093\/cvr\/cvab046","article-title":"Vascular smooth muscle cells in atherosclerosis: time for a re-assessment","volume":"117","author":"Grootaert","year":"2021","journal-title":"Cardiovasc. Res."},{"issue":"24","key":"10.1016\/j.bcp.2026.118467_b0190","doi-asserted-by":"crossref","DOI":"10.3390\/cells11244060","article-title":"Vascular Smooth Muscle Cells Phenotypic Switching in Cardiovascular Diseases","volume":"11","author":"Tang","year":"2022","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.bcp.2026.118467_b0195","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1161\/ATVBAHA.115.306607","article-title":"Deletion of Hyaluronan Synthase 3 Inhibits Neointimal Hyperplasia in mice","volume":"36","author":"Kiene","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.bcp.2026.118467_b0200","doi-asserted-by":"crossref","first-page":"C505","DOI":"10.1152\/ajpcell.00061.2022","article-title":"Hyaluronan in pathophysiology of vascular diseases: specific roles in smooth muscle cells, endothelial cells, and macrophages","volume":"323","author":"Parnigoni","year":"2022","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"11","key":"10.1016\/j.bcp.2026.118467_b0205","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1074\/jbc.RA119.011982","article-title":"Sirtuin 1 reduces hyaluronan synthase 2 expression by inhibiting nuclear translocation of NF-kappaB and expression of the long-noncoding RNA HAS2-AS1","volume":"295","author":"Caon","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.bcp.2026.118467_b0210","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1161\/01.RES.0000158963.37132.8b","article-title":"Overexpression of hyaluronan in the tunica media promotes the development of atherosclerosis","volume":"96","author":"Chai","year":"2005","journal-title":"Circ. Res."},{"issue":"12","key":"10.1016\/j.bcp.2026.118467_b0215","doi-asserted-by":"crossref","DOI":"10.3390\/biom14121567","article-title":"Differential Regulation of Hyaluronan Synthesis by three Isoforms of Hyaluronan Synthases in Mammalian Cells","volume":"14","author":"Wang","year":"2024","journal-title":"Biomolecules"},{"issue":"37","key":"10.1016\/j.bcp.2026.118467_b0220","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1038\/onc.2012.475","article-title":"Efficient TGFbeta-induced epithelial-mesenchymal transition depends on hyaluronan synthase HAS2","volume":"32","author":"Porsch","year":"2013","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.bcp.2026.118467_b0225","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1172\/JCI10272","article-title":"Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme","volume":"106","author":"Camenisch","year":"2000","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.bcp.2026.118467_b0230","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1161\/01.RES.0000119169.87429.A0","article-title":"Induction of hyaluronic acid synthase 2 (HAS2) in human vascular smooth muscle cells by vasodilatory prostaglandins","volume":"94","author":"Sussmann","year":"2004","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.bcp.2026.118467_b0235","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1161\/01.RES.0000199263.67107.c0","article-title":"Differential regulation of hyaluronic acid synthase isoforms in human saphenous vein smooth muscle cells: possible implications for vein graft stenosis","volume":"98","author":"van den Boom","year":"2006","journal-title":"Circ. Res."},{"issue":"9B","key":"10.1016\/j.bcp.2026.118467_b0240","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1111\/j.1582-4934.2009.00736.x","article-title":"Cyclooxygenase inhibitors repress vascular hyaluronan-synthesis in murine atherosclerosis and neointimal thickening","volume":"13","author":"Marzoll","year":"2009","journal-title":"J. Cell Mol. Med."},{"issue":"12","key":"10.1016\/j.bcp.2026.118467_b0245","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1517\/13543776.2015.1090973","article-title":"COX inhibitors: a patent review (2011\u20132014)","volume":"25","author":"Consalvi","year":"2015","journal-title":"Expert Opin. Ther. Pat."},{"issue":"14","key":"10.1016\/j.bcp.2026.118467_b0250","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1007\/s40265-020-01369-x","article-title":"The Expanding Role of the COX Inhibitor\/Opioid Receptor Agonist Combination in the Management of Pain","volume":"80","author":"Varrassi","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.bcp.2026.118467_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114035","article-title":"Hyaluronic acid promotes hepatocellular carcinoma proliferation by upregulating CD44 expression and enhancing glucose metabolism flux","volume":"147","author":"Zhang","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2026.118467_b0260","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/j.ajpath.2013.02.038","article-title":"Interleukin-1beta induces hyaluronan and CD44-dependent cell protrusions that facilitate fibroblast-monocyte binding","volume":"182","author":"Meran","year":"2013","journal-title":"Am. J. Pathol."},{"issue":"27","key":"10.1016\/j.bcp.2026.118467_b0265","doi-asserted-by":"crossref","first-page":"19426","DOI":"10.1074\/jbc.M610054200","article-title":"Heregulin-mediated ErbB2-ERK signaling activates hyaluronan synthases leading to CD44-dependent ovarian tumor cell growth and migration","volume":"282","author":"Bourguignon","year":"2007","journal-title":"J. Biol. Chem."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226008075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226008075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T19:29:26Z","timestamp":1791055766000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226008075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":53,"alternative-id":["S0006295226008075"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118467","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fenbufen suppresses VSMC phenotypic switching and neointimal hyperplasia by targeting HAS2","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118467","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118467"}}